NCT03603600 - Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens | Biotech Hunter

Enrollment

501

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

May 4, 2023

Study Completion Date

May 4, 2023

Conditions

Cataract

Interventions

DEVICE

enVista MX60E

enVista MX60E monofocal IOL

DEVICE

enVista MX60EF

enVista MX60EF (trifocal) multifocal IOL (MIOL)

Trial Locations (23)

16066

Bausch Site 116, Pittsburgh

32757

Bausch Site 107, Mt. Dora

37205

Bausch Site 110, Nashville

38119

Bausch Site 112, Memphis

43215

Bausch Site 109, Columbus

44141

Bausch Site 106, Brecksville

49009

Bausch Site 119, Birmingham

55420

Bausch Site 101, Bloomington

57108

Bausch Site 121, Sioux Falls

60046

Bausch Site 117, Lake Villa

63131

Bausch Site 102, St Louis

68137

Bausch Site 124, Omaha

72703

Bausch Site 108, Fayetteville

75243

Bausch Site 105, Dallas

77008

Bausch Site 111, Houston

78215

Bausch Site 122, San Antonio

78229

Bausch Site 123, San Antonio

78613

Bausch Site 104, Cedar Park

89145

Bausch Site 118, Las Vegas

90505

Bausch Site 103, Torrance

91325

Bausch Site 120, Northridge

96002

Bausch Site 115, Redding

02843

Bausch Site 113, Garden Grove

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY